Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome (Q38937694)

scientific article

Language	Label	Description	Also known as
English	Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

7 September 2017

Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome (English)

1 reference

stated in

Europe PubMed Central

7 September 2017

3

Suzanne D Vernon

1 reference

stated in

Europe PubMed Central

7 September 2017

5

Michael Houghton

1 reference

stated in

Europe PubMed Central

7 September 2017

Abdolamir Landi

1

1 reference

stated in

Europe PubMed Central

PubMed ID

26615570

retrieved

7 September 2017

David Broadhurst

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

26615570

retrieved

7 September 2017

D Lorne J Tyrrell

series ordinal

4

1 reference

stated in

Europe PubMed Central

7 September 2017

23 November 2015

1 reference

stated in

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

78

1 reference

stated in

Europe PubMed Central

7 September 2017

27-36

1 reference

stated in

Europe PubMed Central

7 September 2017

VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

IL-16 is differentially expressed in the developing human fetal brain by microglial cells in zones of neuropoesis.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Cognitive impairments associated with CFS and POTS.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

A direct approach to false discovery rates

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Senescent B lymphopoiesis is balanced in suppressive homeostasis: decrease in interleukin-7 and transforming growth factor-beta levels in stromal cells of senescence-accelerated mice.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Antiangiogenic VEGF-A in peripheral artery disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Cytokine control of memory T-cell development and survival

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Virology. A new virus for old diseases?

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Fit-for-purpose method development and validation for successful biomarker measurement.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Chronic fatigue syndrome: the need for subtypes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Hepatic interleukin-7 expression regulates T cell responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Factors that may impact on immunosenescence: an appraisal

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Signal transduction and regulation in smooth muscle

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Plasma cytokines in women with chronic fatigue syndrome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Statistical strategies for avoiding false discoveries in metabolomics and related experiments

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Recombinant origin of the retrovirus XMRV.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Cytokines across the night in chronic fatigue syndrome with and without fibromyalgia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Decreased Expression of VEGF-A in Rat Experimental Autoimmune Encephalomyelitis and in Cerebrospinal Fluid Mononuclear Cells from Patients with Multiple Sclerosis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Improving the diagnostic criteria and procedures for chronic fatigue syndrome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Reversible modulations of neuronal plasticity by VEGF.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Vascular endothelial growth factor promotes proliferation of cortical neuron precursors by regulating E2F expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Unintended Consequences of not Specifying Exclusionary Illnesses for Systemic Exertion Intolerance Disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

A formal analysis of cytokine networks in chronic fatigue syndrome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Molecular quantitation of thymic output in mice and the effect of IL-7.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

VEGF reverts the cognitive impairment induced by a focal traumatic brain injury during the development of rats raised under environmental enrichment

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Distinct plasma immune signatures in ME/CFS are present early in the course of illness

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Il-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the Solv

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Interleukin-7: from bench to clinic

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Production of IL-16 correlates with CD4+ Th1 inflammation and phosphorylation of axonal cytoskeleton in multiple sclerosis lesions

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

The critical role of VEGF in skeletal muscle angiogenesis and blood flow

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Replication of an empirical approach to delineate the heterogeneity of chronic unexplained fatigue.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Interleukin-7 is trophic for embryonic neurons and is expressed in developing brain.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Age-associated thymic atrophy is linked to a decline in IL-7 production

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Chronic fatigue syndrome and circulating cytokines: A systematic review

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

VEGF links hippocampal activity with neurogenesis, learning and memory

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Immunosenescence of ageing

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

VEGF: a surrogate marker for peripheral vascular disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Human mid-gestation amniotic fluid contains interleukin-16 bioactivity.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndrome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Cytokine expression provides clues to the pathophysiology of Gulf War illness and myalgic encephalomyelitis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Cytokines in the cerebrospinal fluids of patients with chronic fatigue syndrome/myalgic encephalomyelitis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Identifiers

DOI

10.1016/J.CYTO.2015.11.018

1 reference

stated in

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

PubMed ID

26615570

retrieved

7 September 2017

ResearchGate publication ID

285045223

0 references

Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome (Q38937694)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome (Q38937694)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search